Tofersen – March 2026

Solution for intrathecal injection 100 mg in 15 mL

  • Brand names:
    • Qalsody®
  • Pharmaceutical Company:
    • BIOGEN AUSTRALIA PTY LTD
  • Condition/Indication: Amyotrophic lateral sclerosis (ALS)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026